Retraction notices

Evaluation of the Safety and Efficacy of Bremelanotide, a Melanocortin Receptor Agonist, in Female Subjects with Arousal Disorder: A Double-Blind Placebo-Controlled, Fixed Dose, Randomized Study

Type: Retraction
Notice date: 7/11/2021 0:00
Journal: Journal of Sexual Medicine
Publisher: Elsevier
Notice DOI: 10.1111/j.1743-6109.2007.00698.x
Original paper DOI: 10.1111/j.1743-6109.2007.00698.x

Reasons